Baxter International Inc. (BAX)

NYSE: BAX · Real-Time Price · USD

21.58

+0.24 (1.12%)

At close: Feb 20, 2026, 4:00 PM EST

21.60

+0.02 (0.09%)

After-hours: Feb 20, 2026, 7:24 PM EST

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
United States Revenue	6.12B	5.85B
United States Revenue Growth	4.65%	0.83%
Emerging Markets Revenue	1.39B	1.35B
Emerging Markets Revenue Growth	3.26%	0.52%
Rest of World Revenue	3.73B	3.44B
Rest of World Revenue Growth	8.50%	6.87%
Revenue (Total)	11.24B	10.64B
Revenue (Total) Growth	5.72%	2.66%

Revenue Breakdown

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Infusion Therapies Revenue	4.10B	4.10B
Infusion Therapies Revenue Growth	-0.05%	3.61%
Advanced Surgery Revenue	1.20B	1.10B
Advanced Surgery Revenue Growth	8.51%	5.04%
Medical Products & Therapies Revenue	5.30B	5.21B
Medical Products & Therapies Revenue Growth	1.77%	3.91%
Care & Connectivity Solutions Revenue	1.91B	1.81B
Care & Connectivity Solutions Revenue Growth	5.35%	0.78%
Front Line Care Revenue	1.16B	1.14B
Front Line Care Revenue Growth	2.02%	-6.26%
Healthcare Systems & Technologies Revenue	3.07B	2.95B
Healthcare Systems & Technologies Revenue Growth	4.07%	-2.06%
Injectables and Anesthesia Revenue	1.35B	1.37B
Injectables and Anesthesia Revenue Growth	-1.53%	1.93%
Drug Compounding Revenue	1.14B	1.04B
Drug Compounding Revenue Growth	9.92%	15.08%
Pharmaceuticals Revenue	2.49B	2.41B
Pharmaceuticals Revenue Growth	3.40%	7.20%
Other Revenue (Post-Q2 2023 Reporting)	381.00M	67.00M
Other Revenue (Post-Q2 2023 Reporting) Growth	468.66%	-22.99%
Revenue (Total)	11.24B	10.64B
Revenue (Total) Growth	5.72%	2.66%

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Medical Products & Therapies Operating Income	970.00M	950.00M
Medical Products & Therapies Operating Income Growth	2.10%	-2.26%
Healthcare Systems & Technologies Operating Income	441.00M	468.00M
Healthcare Systems & Technologies Operating Income Growth	-5.77%	-3.11%
Pharmaceuticals Operating Income	222.00M	313.00M
Pharmaceuticals Operating Income Growth	-29.07%	-21.95%
Other Operating Income	43.00M	18.00M
Other Operating Income Growth	138.89%	-
Operating Income (Total)	-308.00M	14.00M
Operating Income (Total) Growth	-	-98.02%

Updated Feb 12, 2026. Data Source: Fiscal.ai.